Company Overview of Materia Medica Holdings Ltd.
Materia Medica Holdings Ltd. engages in the research and manufacturing of homeopathic products. It offers Anaferon, a drug for prevention and treatment of influenza and SARS; Anaferon for children for the treatment and prevention of influenza; Arthrofoon, a drug for course treatment of chronic inflammatory diseases of joints; Afala, a drug for treatment of prostatitis and benign prostate hyperplasia; and Impaza, a product for course treatment of erectile dysfunction of different etiology. The company also provides Proproten-100, a drug for the treatment of alcoholism; Tenoten for acute and chronic stresses and neurosis-like conditions; and Tenoten for children for the treatment of attention ...
3rd Samotechniy per
Founded in 1992
Key Executives for Materia Medica Holdings Ltd.
Materia Medica Holdings Ltd. does not have any Key Executives recorded.
Materia Medica Holdings Ltd. Key Developments
Materia Medica Holdings Ltd. Presents at BIO International Convention 2015, Jun-16-2015 04:45 PM
Jun 11 15
Materia Medica Holdings Ltd. Presents at BIO International Convention 2015, Jun-16-2015 04:45 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Sergey Tarasov, Head of Research and Analytical department.
Materia Medica Holdings Ltd. Presents at 12th Annual BIO Asia International Conference, Mar-25-2015 02:30 PM
Mar 12 15
Materia Medica Holdings Ltd. Presents at 12th Annual BIO Asia International Conference, Mar-25-2015 02:30 PM. Venue: Grand Hyatt Hotel, Tokyo, Japan.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries